en, English

our partners

Companies with which we constantly and productively cooperate.


EuropaBio ("The European Association for Bioindustries") is Europe's largest and most influential biotech industry group. The organisation was initiated in 1996 to represent the interests of the biotechnology industry at European level and therefore influence legislation that serves the interests of biotechnology companies in Europe.

World Health Organization

The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group.

International Agency for Research on Cancer

The International Agency for Research on Cancer is an intergovernmental agency forming part of the World Health Organization of the United Nations. Its role is to conduct and coordinate research into the causes of cancer. It also collects and publishes surveillance data regarding the occurrence of cancer worldwide.

German Cancer Research Center

The German Cancer Research Center (Deutsches Krebsforschungszentrum (DKFZ) - German Cancer Consortium), is a national cancer research center based in Heidelberg, Germany. It is a member of the Helmholtz Association of German Research Centres, the largest scientific organization in Germany.

Deutsche Forschungsgemeinschaft

The Deutsche Forschungsgemeinschaft is a German research funding organization. The DFG supports research in science, engineering, and the humanities through a variety of grant programmes, prizes and by funding infrastructure. As of 2018, the organization consists of approx. 100 research universities and other research institutions.

German Cancer Aid

The German Cancer Aid (German: Deutsche Krebshilfe) is a not-for-profit organization to fight cancer in all its forms. It became the leading organization fighting cancer in Europe. The German Cancer Aid has remained independent of politics and the pharmacological industry. The organization sponsors and supports research projects to improve prevention, diagnosis, therapy, after-care and self-help.

Bundesministerium für Gesundheit

The Federal Ministry of Health (Bundesministerium für Gesundheit), abbreviated BMG. It is the highest German federal government department responsible for health. The ministry is officially located in Bonn and with a second office, which houses the ministry's management in Berlin.

Federal Institute for Drugs and Medical Devices

The Federal Institute for Drugs and Medical Devices (in German: Bundesinstitut für Arzneimittel und Medizinprodukte - BfArM) is a medical regulatory body in Germany.

Deutsche Krebsgesellschaft

The German Cancer Society e. V. is the first and largest oncological society in Germany. Its goal is to prevent cancer, to improve its treatment and to improve the quality of life of people with cancer. The 16 national cancer companies form the A section of the DKG, while currently (Jan 2019), Section B comprises 7,960 individual members, as well as physicians, basic researchers, medical-technical assistants, nursing staff, psychologists and other professional groups.

Deutsche Bank

Deutsche Bank AG is the largest lending institution in Germany in terms of total assets and number of employees. The bank is operational in 58 countries with a large presence in Europe, the Americas and Asia. As of April 2018, Deutsche Bank is the 15th largest bank in the world by total assets.

European Organisation for Research and Treatment of Cancer

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 (Belgium). It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients.

European Network for Health Technology Assessment

European network for health technology assessment (EUnetHTA) is a network, established to create an effective and sustainable network for health technology assessment (HTA) across Europe that could develop and implement practical tools to provide reliable, timely, transparent and transferable information to contribute to HTAs in members states.

Institute for Quality and Efficiency in Health Care

The Institute for Quality and Efficiency in Healthcare (IQWiG) (German: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions, diagnostic and screening methods, and treatment and disease management. IQWiG also supplies health information to patients and the general public.

Federal Joint Committee (Germany)

The Federal Joint Committee (German: Gemeinsamer Bundesausschuss) (G-BA) is the highest body of common self-government in health care in Germany. He is mandated by the legislature to make legally binding decisions in many areas on the entitlement to benefits of the solidarity community of about 73 million people with statutory health insurance in Germany. The G-BA is often referred to as the "small legislator" or the "Central Committee of the Health Service".

European Commission

The European Commission (EC) is an institution of the European Union, responsible for proposing legislation, implementing decisions, upholding the EU treaties and managing the day-to-day business of the EU. The Commission was set up from the start to act as an independent supranational authority separate from governments. The Commission differs from the other institutions in that it alone has legislative initiative in the EU. Only the Commission can make formal proposals for legislation: they cannot originate in the legislative branches.

German Institute for Medical Documentation and Information

The German Institute for Medical Documentation and Information (Deutsches Institut für Medizinische Dokumentation und Information - DIMDI) is a subordinate authority of the Federal Ministry of Health. Its tasks include making current information from the entire field of medicine easily and quickly accessible to the interested public. The institute operates special information systems for pharmaceuticals, medical devices and health technology assessment (HTA) as well as for research purposes an information system with health insurance data.

Association of the Scientific Medical Societies in Germany

(Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF) of Germany advises on matters and tasks of fundamental and interdisciplinary interest in medicine, develops recommendations and resolutions and represents them at the institutions occupied with such tasks, i.e. in the area of research strategies, education, and postgraduate training. AWMF intends to see that the interests of the medical sciences are accepted positively by the general public. AWMF advises the government of the Federal Republic of Germany.

Cochrane Collaboration

Cochrane Collaboration is an international non-profit organization that studies the effectiveness of medical technologies (health technologies) by critically evaluating, analyzing and synthesizing research results using a rigorous systematized methodology, which Collaboration is constantly improving. The organization publishes the results of these studies in the form of “Cochrane systematic reviews” in its database - the Cochrane Library. Cochrane is in official relations with the World Health Organization (WHO), participates in meetings of the Executive Board and the World Health Assembly, and provides information support for the process of developing guidelines for WHO.

The DGHO German Society for Hematology and Medical Oncology e.V.

The DGHO German Society for Hematology and Medical Oncology e.V. is an association of physicians, scientists and interested persons who specialize in the research, diagnosis and treatment of blood diseases and malignant solid tumors. The DGHO currently has more than 3,400 members. Annual conference with more than 5,000 participants, jointly organized with the Austrian Society of Hematology and Medical Oncology (OeGHO), the Swiss Society of Medical Oncology (SGMO) and the Swiss Society of Hematology (SGH + SSH).

The Association of German Tumor Centers e.V. (ADT)

In 1978, the tumor centers of Germany joined together and founded the Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT). It aims for cross-sectoral (outpatient and inpatient), nationwide, population-based and high-quality care for patients. Today, the ADT includes 60 tumor centers, oncology specialties, Comprehensive Cancer Centers (CCC) and clinical cancer registries. Together with other organizations, the ADT acts i.a. as co-initiator and implementer of the recommendations of the National Cancer Plan.

The Association of University Clinics of Germany (VUD)

The Association of University Hospitals in Germany (Der Verband der Universitätsklinika Deutschlands - VUD) represents the interests of university hospitals in Germany. VUD represents the interests of all 34 university hospitals in Germany. VUD represents the interests of university hospitals and seeks to improve the economic and legal environment for its members. The goal is to continue to provide patients with high-quality drugs and introduce new methods of examination and treatment in the health care system. As hospitals of the highest level of medical care, the university hospitals take over patients with particularly difficult and complicated illnesses.

European Federation of Biotechnology

The European Federation of Biotechnology (EFB) is Europe’s non-profit federation of National Biotechnology Associations, Learned Societies, Universities, Scientific Institutes, Biotech Companies and individual biotechnologists working to promote biotechnology throughout Europe and beyond. As the independent “Voice of Biotechnology in Europe”, EFB promotes the safe, sustainable and beneficial use of fundamental research and innovation in life sciences, while providing a forum for interdisciplinary and international cooperation.

The Swiss Society of Medical Oncology (SGMO)

The Swiss Society of Medical Oncology (Der Schweizerischen Gesellschaft für Medizinische Onkologie - SGMO). The SGMO, together with other specialist societies and professional organizations, ensures optimal treatment and care for cancer patients. Defines quality standards for the treatment and care of cancer patients together with other specialist societies and professional organizations. Is responsible for further education. Represents the interests of all medical oncologists, regardless of the care structure (hospital and practice).

German Society of Urology

The German Society for Urology eV. (Die Deutsche Gesellschaft für Urologie e. V. - DGU) is a German scientific society for urology based in Düsseldorf. For over 60 years, the professional association represents the professional and professional interests of the specialists in urology in Germany. He supports and advises his members on technical, economic, political and professional issues. At the same time, as the largest lobby association in the field, it not only participates in the development of the job profile, but also actively participates in health policy decision-making processes.

The Austrian Society of Urology and Andrology

The Austrian Society of Urology and Andrology (ÖGU) is a non-profit association with the purpose to promote urology and andrology as well as both border areas by joint work of its members in the fields of science, research and training, to provide a urological supply according to the latest state of health to ensure medical science. To this end, it organizes an annual training conference, seminars, teaching and training events, conducts scientific research and publishes study results. As a scientific society, it represents the interests of urologists and andrologists towards public-law bodies and institutions.

The European Association of Urology (EAU)

The European Association of Urology (EAU) is a non-profit organisation committed to the representation of urology professionals worldwide. The General Assembly, the EAU’s highest decision-making body, is mandated to pass resolutions which are necessary to achieve the goals of the association, except those resolutions which are part of the responsibilities of the Executive Committee. The EAU maintains close contacts with national urology organisations who represent the interests of urologists at a national level worldwide. These independent national organisations are crucial as they support the EAU and its European activities

Federal Office of Public Health

The Federal Office of Public Health (FOPH) (Das Bundesamt für Gesundheit (BAG);  französisch Office fédéral de la santé publique (OFSP), italienisch Ufficio federale della sanità pubblica (UFSP)) is the Swiss federal government’s centre for public health and a part of the Swiss Federal Department of Home Affairs. The FOPH is responsible for national health policy and - together with the cantons - for promoting the health of the Swiss population. In addition to developing national health policy, it also represents the interests of its country within international health organizations such as the OECD or the World Health Organization. Based in Bern Switzerland.

European Commission Initiative on Breast Cancer

European Commission Initiative on Breast Cancer (ECIBC) is a person-centred initiative to improve breast cancer care. The JRC, with ECIBC, is developing the most up-to-date evidence-based recommendations on screening and diagnosis, with a platform of trustworthy guidelines for the whole care pathway.

The Swiss Society of Urology

The Swiss Society for Urology (Die Schweizerische Gesellschaft für Urologie - SWISS UROLOGY) was founded on October 27, 1944 in Geneva. The SGU also issues guidelines for the investigation, treatment and follow-up of urological diseases. She also gives recommendations for educating patients about urological surgeries.

The Journal of Evidence and Quality in Health Care

The Journal of Evidence and Quality in Health Care (Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen - ZEFQ) is a bilingual German and English language peer-reviewed medical journalpublished by Elsevier Germany. ZEFQ is the organ of various organisations working in the fields of evidence-based medicine, patient empowerment, patient safety, and quality management in healthcare.

Federal Ministry of Health and Women

The Federal Ministry of Health and Women (Das Bundesministerium für Gesundheit und Frauen (BMGF; in Kurzform: Gesundheitsministerium) abbreviated to BMGF, in short: Ministry of Health) described the Ministry of Austria, which is primarily responsible for the health sector.

The Health Austria GmbH (GÖG)

The Health Austria GmbH (GÖG) is the National Research and Planning Institute of Public Health and focal point for health promotion. Gesundheit Österreich is a holding company with three business divisions: the Austrian Federal Institute for Health Care (ÖBIG), the Healthy Austria Fund (FGÖ), the Federal Institute for Quality in Health Care (BIQG). The sole shareholder of Health Austria is the Republic of Austria, represented by the Federal Minister of Health. Organizational basis is the Federal Law on Health Austria GmbH (GÖGG).

The Healthy Austria Fund (FGÖ)

The Healthy Austria Fund (Der Fonds Gesundes Österreich FGÖ) is a public body whose purpose is health promotion and disease prevention. Through information, education and public relations, the population of Austria should be motivated to choose a healthy lifestyle. In addition, the Healthy Austria Fund supports practice-oriented and scientific projects, the development of structures as well as training and networking in health promotion. As a networked organization promote inward and outward action and intersectoral cooperation.

The Federal Institute for Quality in Health Care (BIQG)

The Federal Institute for Quality in Health Care (Das Bundesinstitut für Qualität im Gesundheitswesen - BIQG) was founded in 2007 on the basis of the 2004 passed Health Quality Act (GQG). On behalf of the federal government, the BIQG is responsible for the development, implementation and regular evaluation of a nationwide quality system. According to the GQG, all work carried out by the BIQG is based on the basic principles of uniformity across the federal state, cross-sectoral and cross-sectoral approaches, patient orientation and transparency, effectiveness and efficiency in accordance with international standards.

Austrian Federal Institute of Health (ÖBIG)

Austrian Federal Institute of Health (Das Österreichische Bundesinstitut für Gesundheitswesen ÖBIG) was founded in 1973. The central task of the young institute was to develop data collection methods that should provide information on the state of public health. On August 1, 2006, ÖBIG was incorporated as a division of Gesundheit Österreich GmbH. The tasks of ÖBIG are defined in the GÖG Law. The focus is on the development of information bases, methods and tools for supra-regional or national planning, monitoring and evaluation in the health sector.

IceCure Medical

IceCure Medical is an Israeli medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and painlessly without the need for surgery. IceCure’s next generation cryoablation technology, the ProSense™ system, enables rapid minimally-invasive, safe, and effective treatment of breast lesions in-office or ambulatory hospital settings. The ProSense™ system is a proven solution for the treatment of benign and malignant breast tumors, as well as renal, lung, and bone cancer. In October 2018, the American Association of Breast Surgeons adapted its guidelines following the ProSense ICE3 trial, supporting accelerated investigations of cryoablation technology for treatment of malignant breast tumors.


Real Imager 8 (RI8) provides a no touch, no radiation and woman-friendly procedure to determine the likelihood of breast cancer through non-invasive imaging procedure. The imaging data is assessed objectively and a RIsk Assessment Score is provided to the physician. Unlike mammography, the Real Imager 8 does not invovle compression of the breast, which is sometimes painful to many women. MIRA utilizes dual-head proprietary Structured Light Projection Infrared imaging technology to construct 3-D vascular maps of the breasts. 


Biop Medical is developing an innovative technology, intended for assisting physicians to identify cancerous and pre-cancerous cells in epithelial tissues. The Biop system enables scanning of the entire cervix, generating real-time a high-resolution and high-magnification visualization of the cervix. Immediately after scan completion , physicians will be able to give their patients a near certain diagnosis, eliminating the prolonged waiting time and anxiety associated with the current, inefficient diagnosis process. 


RealView Imaging employs its proprietary Digital Light Shaping technology to create a unique hyper-realistic experience for visualization of medical images, empowering clinicians with intuitive comprehension of complex 3D structures. The HOLOSCOPE product line provides full color, high resolution, dynamic and interactive 3D images in free space from any medical 3D volumetric data. The HOLOSCOPE is the world's first medical holographic system that provides image intimacy capabilities for direct and precise interaction with and within the holographic images.

Burson Cohn & Wolfe Sprl

Burson Cohn & Wolfe Sprl (BCW) is part of one of the world’s leading public relations and public affairs companies, which gives BCW access to the knowledge, experience and insights of colleagues in a worldwide network active in 112 countries around the world. BCW's European network gives the insight and expertise to offer an integrated and complete service to their clients. BCW is a multicultural team with years of experience advising clients on all EU policy areas, including competition, technology, tax, environment, food, healthcare, energy, transport, sport, foreign affairs and defence. 

Interel European Affairs

As the world’s largest independent, global public affairs and association management consultancy, Interel is at the nexus of business, policy, and advocacy. For more than 35 years, Interel award-winning team of over 1,000 consultants in 70 markets has delivered targeted solutions that achieve successful outcomes for clients worldwide. Interel harness global best practices and deep local connections to provide practical intelligence that creates opportunities for corporate, association, and professional society clients everywhere.

European Alliance for Personalised Medicine

The European Alliance for Personalised Medicine was launched in March 2012, with the aim of improving patient care by accelerating the development, delivery and uptake of personalised medicine and earlier diagnostics, through consensus. Alliance began life as a response to the need for a wider understanding of priorities in personalised medicine and a more integrated approach among distinct lay and professional stakeholders. Continues to fulfil that role, not least through regular major events and non-stop media interaction, the publication of Special Issues and more.

MedTech Europe

MedTech Europe is the European trade association representing the medical technology industries, from diagnosis to cure. It represents Diagnostics and Medical Devices manufacturers operating in Europe. It is born as an alliance of two European medical technology associations, EDMA and Eucomed, representing the European IVD and medical device industries, respectively. It was established with the aim to represent the common policy goals of both organisations more effectively, promoting the interests of its members and of the medical technology industry in general. The MedTech Europe alliance members organise the largest health and medical technology industry conference in Europe, the MedTech Forum.

The European Cancer Organisation (ECCO)

The European Cancer Organisation (ECCO), represents the interests of over 150,000 oncology professionals and promotes the multidisciplinarity of the field. The organisation connects the European cancer community by leveraging knowledge, promoting education and building awareness. ECCO also plays an important role in engaging with policymakers to promote the interests of cancer patients, research as well all other members of the oncocommunity. The organisation is renowned for its prestigious biennial series of multidisciplinary congresses.

ecancer Global Foundation's

The ecancer Global Foundation's mission is to raise the standards of care for cancer patients the world over. ecancer.org is a completely free online knowledge bank incorporating an open-access journal, news, video, and e-learning (in both English and Spanish).  ecancer also run medical education events all over the world, helping to connect the healthcare community to practice changing knowledge. ecancer.org was founded in 2007 by two inspirational oncologists, Prof Gordon McVie, and Prof Umberto Veronesi, who shared a mission to optimise patient care and outcomes by improving cancer communication and education. 

Union for International Cancer Control (UICC)

The Union for International Cancer Control's rapidly increasing membership base of over 1100 organisations in more than 170 countries, represents the world’s major cancer societies, ministries of health and patient groups and includes influential policy makers, researchers and experts in cancer prevention and control. UICC also boasts more than 50 strategic partners. Their mission statement is: "To unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda. Geneva, CHE.

The Organisation of European Cancer Institutes (OECI)

The OECI is a non-government, non-profit organisation founded in Vienna in 1979 with the primary objectives to improve communication and to bring together the cancer research and care institutions of the European Union, in order to create a critical mass of expertise and competence. The organisation’s head office is located in Brussels at the University Foundation. The OECI is a network presently regrouping almost 100 Members collaborating to reduce fragmentation and to give to all European cancer patients the possibility of receiving the best available care.

European Society of Breast Cancer Specialists (EUSOMA)

EUSOMA is a non-profit Society that promotes the multidisciplinary approach to breast cancer diagnosis and treatment. EUSOMA is committed in promoting interaction between all the health professionals involved in breast cancer care with the aim of ensuring that all patients with breast cancer have equitable access to high quality care delivered by multidisciplinary breast teams. EUSOMA is directly involved in setting evidence based standards that forms the basis for certification of breast centres in Europe. EUSOMA Head Office is located in Florence, Italy .

The European Breast Cancer Coalition (EUROPA DONNA)

EUROPA DONNA - The European Breast Cancer Coalition is an independent, non-profit organisation whose members are affiliated groups from countries throughout Europe. The Coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and care and increased funding for research. EUROPA DONNA represents the interests of European women regarding breast cancer to local and national authorities and to institutions of the European Union. EUROPA DONNA has 46 member Countries.

Joint Research Centre (JRC)

The Joint Research Center, the more well-known JRC, is the Head Office for the European Commission, located in Brussels (Belgium), which is responsible for providing independent scientific and technical advice to the European Commission and the Member States of the European Union (EU). Composed of strategy and coordination, knowledge production, knowledge management and support directorates, the JRC is spread across six sites in five different countries within the EU: in Belgium (Brussels and Geel), Germany (Karlsruhe), Italy (Ispra), the Netherlands (Petten), and Spain (Seville).

The European Cancer Patient Coalition (ECPC)

ECPC is the largest European cancer patients' umbrella organisation. The European Cancer Patient Coalition (ECPC) is the voice of cancer patients in Europe. With over 400 members, ECPC is Europe’s largest umbrella cancer patients’ association, covering all 28 EU member states and many other European and non-European countries. ECPC represents patients affected by all types of cancers, from the rarest to the most common. The European Cancer Patient Coalition is an international non-profit association registered under Belgian law (Association Internationale sans but lucratif - AISBL).

The European Society for Medical Oncology (ESMO)

The European Society for Medical Oncology (ESMO) is Europe’s leading non-profit medical oncology organisation. We are a membership-based society: 500 expert committee members and over 20,000 oncology professionals.

ESMO organises a large number of meetings to provide its members and the community with the resources they need and also plays a major role in Public Policy and European affairs. ESMO seeks to erase boundaries in cancer care, whether between countries or specialities, and pursue its mission across oncology, worldwide.

International Women Health and Breast Cancer Conference (iWomen)

i-Women Health 2019 includes nearly every permutation of knowledge, innovation, technology and networking. We have an objective of creating an international forum for academicians, practitioners, health and business professionals who work across the broad field of women's health to share latest advancement and research that will enable the best outcomes for women patients. i-Women Health's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment for women across the lifespan.

The European Chemicals Agency (ECHA)

The European Chemicals Agency (ECHA) is an agency of the European Union which manages the technical and administrative aspects of the implementation of the European Union regulation called Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). ECHA is the driving force among regulatory authorities in implementing the EU's chemicals legislation. ECHA helps companies to comply with the legislation, advances the safe use of chemicals, provides information on chemicals and addresses chemicals of concern. It is located in Helsinki, Finland.

European Environment Agency (EEA)

The European Environment Agency (EEA) is an agency of the European Union, whose task is to provide sound, independent information on the environment. The EEA aims to support sustainable development by helping to achieve significant and measurable improvement in Europe's environment, through the provision of timely, targeted, relevant and reliable information to policymaking agents and the public. Through Eionet, the EEA brings together environmental information from individual countries concentrating on the delivery of timely, nationally validated, high-quality data.


NanoAF developed, manufactures and sells a novel coating which prevents bacterial adhesion to surfaces. The coating spontaneously formed by the self-assembly of a tripeptide. The advantages of using peptides for this purpose are concealed in peptides' biocompatibility, chemical diversity, and ease for large scale synthesis. The coating is formed by the peptide on various surfaces (glass, titanium, silicon oxide, metals and polymers). NanoAF coating completely prevents the first step of fouling which involves the adsorption of bioorganic molecules to the substrate.

The German Federal Institute for Risk Assessment (BfR)

The German Federal Institute for Risk Assessment (German: Bundesinstitut für Risikobewertung - BfR), is a body under public law of the German federal government with full legal capacity. The institute comes under the portfolio of the Federal Ministry of Food and Agriculture (German: Bundesministeriums für Ernährung und Landwirtschaft, BMEL) and has the task of providing scientific advice to the federal government on issues relating to food safety, product safety, chemical safety, contaminants in the food chain, animal protection and consumer health protection.

The European Food Safety Authority (EFSA)

The European Food Safety Authority (EFSA) is the agency of the European Union (EU) that provides independent scientific advice and communicates on existing and emerging risks associated with the food chain. The work of EFSA covers all matters with a direct or indirect impact on food and feed safety, including animal health and welfare, plant protection and plant health and nutrition. EFSA supports the European Commission, the European Parliament and EU member states in taking effective and timely risk management decisions that ensure the protection of the health of European consumers and the safety of the food and feed chain.

Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (ZLG)

The ZLG is the designating authority. Recognition and naming requirements and procedures for. Conformity Assessment Bodies conducting US state, Canadian, Australian and New Zealand testing. laboratories. Certification bodies for medical devices and in vitro diagnostic medical devices. Certification bodies for personnel. Certification bodies for quality management systems. Sectoral committees and exchange of experience of notified bodies and laboratories. Competent authorities nationally and internationally.

Zurich Insurance Group

Zurich Insurance Group Ltd. is a Swiss insurance company, commonly known as Zurich, headquartered in Zürich, Switzerland. The company is Switzerland's largest insurer. Zurich, the largest insurance group in Switzerland, ranks fifth among primary insurers worldwide. 29 out of 30 DAX companies are insured with Zurich. 

The German Chemical Industry Association e. V. (VCI)

The German Chemical Industry Association e. V. (Der Verband der Chemischen Industrie e. V. - VCI) is the business association of the chemical industry in Germany based in Frankfurt am Main. The VCI is a registered association and member of the Federation of German Industry. He represents the industry's interests in politics and government, as well as other sectors of business, academia and the media. As a member of the European chemical industry association CEFIC (European Chemical Industry Council) he is actively involved in European lobbying.

The German Industry Association for Biotechnology (DIB)

The German Industry Association for Biotechnology (Die Deutsche Industrievereinigung Biotechnologie - DIB) is the biotechnology association of the German Chemical Industry Association e. V. (VCI), its specialist associations and trade associations. It represents the economic policy interests of companies that use biotechnological methods and thus strengthen sustainable growth and the international competitiveness of biotechnology in Germany. In addition, the membership of the DIB includes 10 associations.

European Movement Germany

European Movement Germany (Die Europäische Bewegung Deutschland e. V.) The largest network for European politics in Germany: 249 member organizations from society and economy. Founded in 1949. European Movement Germany is a non-partisan network of interest groups in the field of EU politics in Germany. It cooperates closely with all EU stakeholders on a national and European level, most particularly with the German Federal Government and the European Commission. The EM Germany network is a member of European Movement International.


Edelman is a global communications firm that partners with businesses and organizations to evolve, promote and protect their brands and reputations. Our 6,000 people in more than 60 offices deliver communications strategies that give our clients the confidence to lead, act with certainty and earn the lasting trust of their stakeholders. We develop powerful ideas and tell magnetic stories that move at the speed of news, make an immediate impact, transform culture and spark movements. Since our founding in 1952 by Dan Edelman, we have remained an independent, family-run company.

Roland Berger

Roland Berger is a global strategy consulting firm headquartered in Munich, with 50 offices in 36 countries. The company was founded under the name Roland Berger Strategy Consultants in 1967 by Roland Berger. Roland Berger provides restructuring and marketing advice, but its practice areas also include corporate development, corporate finance, information management, operations strategy, performance improvement, and strategy development. This makes Roland Berger Strategy Consultants the largest strategy consultancy of European origin and the fifth largest in the world. In Germany, she occupies second place in terms of market share to McKinsey.

International Diabetes Federation

The International Diabetes Federation (IDF) is a worldwide alliance of over 230 national diabetes associations in more than 160 countries, who have come together to enhance the lives of people with diabetes everywhere. The Federation is committed to raising global awareness of diabetes, promoting appropriate diabetes care and prevention, and encouraging activities towards finding a cure for the different types of diabetes. The Federation has been leading the global diabetes community since 1950. It is headquartered in Brussels, Belgium. Projects include advocacy and lobbying work, education for people with diabetes and their healthcare providers, public awareness and health improvement campaigns, as well as the promotion of the free exchange of diabetes knowledge.

The Maria Sklodowska-Curie Institute — Oncology Center

The Maria Sklodowska-Curie Institute — Oncology Center in Warsaw with its branches in Cracow and Gliwice conduct research on the causes of cancer and the mechanisms by which this develops.  The Warsaw site is the biggest comprehensive cancer center in Poland which provides 741 patient beds and employs 437 doctors. The best oncological staff available in Poland ensure that effective cancer treatment is delivered using highly specialized procedures and therapies. The Polish Cooperation Office with EORTC was established in October 2011 and began its work in March 2012. The main task of the office is to ensure the rapid opening of new research projects of EORTC in Poland and the support of Polish researchers in conducting clinical trials of EORTC.

Charité Com-pre-hen-sive Can-cer Cen-ter

The Charité Comprehensive Cancer Center (CCCC) is the integrative tumor center of the Charité - Universitätsmedizin Berlin. The CCCC organizes and coordinates cooperation in the field of tumor medicine across the various Charité centers, the interdisciplinary tumor ambulances, the specialist disciplines and the Berlin research institutions. The American weekly Newsweek and the Statista data portal ranked fifth in the ranking of the 1000 best clinics in the world. This makes Charité, according to Newsweek and Statista, the best clinical center in Europe. It is the seventh year in a row: The Charité - Universitätsmedizin Berlin occupies the top spot in the national comparison of hospitals in the now published hospital ranking of the news magazine Focus. Thus, the Charité tops the list of the top 100 clinics in Germany.


Unicancer brings together the French Comprehensive Cancer Centres around a shared medical scientific project and pools their strategic activities: research, purchasing, human resources, hospital strategy, quality control and information systems. Unicancer brings together the French Comprehensive Cancer Centers (FCCCs), promotes their cancer research organisation and pools resources and competencies to give a new dynamic to patient care. They have a threefold mission: patient care, research and teaching. Unicancer builds on the historical community of the FCCCs and accentuates what has always been their strength: cooperating and creating synergies between different teams within the network.

European Centre for Development Policy Management (ECDPM)

European Centre for Development Policy Management (ECDPM) is a leading independent think tank that wants to make policies in Europe and Africa work for inclusive and sustainable development. Our partners include officials from ministries and institutions, international organisations, think tanks, academia and social and economic actors from Africa, Europe and beyond. We have two offices: in Maastricht (the Netherlands) and Brussels (Belgium). We have over thirty years of experience in development policy and international cooperation and know the African and European institutions inside out.

Teneo Brussels

Teneo is the global CEO advisory firm. Working exclusively with the CEOs and senior executives of the world’s leading companies, Teneo provides strategic counsel across their full range of key objectives and issues. Our clients include a significant number of the Fortune 100 and FTSE 100, as well as other global corporations. The Teneo team in Brussels work across all key European markets, offering strategic advice to leaders of Europe-based and global corporations. Teneo’s government and public affairs offering in Brussels and EU Member States provides strategic counsel and tactical execution to the leaders of large and complex businesses on navigating today's volatile geopolitical landscape. Our team of senior specialists have deep expertise in the top policy priorities of the EU.


Quirónsalud or Grupo Hospitalario Quirónsalud is the largest Spanish hospital group. The group operates 44 clinics and 63 other health care facilities, including: a. in Madrid, Barcelona and several other Spanish cities. It was taken over by the German pharmaceutical company Fresenius SE in 2016 for 5.76 billion euros and merged with Germany's largest private hospital chain, Helios.

Fresenius Helios

Fresenius owns the Helios Kliniken, which has more than 110 hospitals and more than 30,000 beds, treating over 4 million patients annually. The hospital operator is the biggest provider of inpatient and outpatient care in Germany. Fresenius Helios is Europe’s leading private hospital operator, with more than 100,000 employees. Fresenius Helios owns and operates Helios hospitals in Germany and Quirónsalud hospitals in Spain. Both Helios and Quirónsalud are the largest private hospital operators in their respective national markets. The 86 hospitals across Germany operated by Helios include seven maximum care facilities – in Berlin, Duisburg, Erfurt, Krefeld, Schwerin, Wiesbaden and Wuppertal. Berlin-based Helios employs about 66,000 people. Quirónsalud operates 47 hospitals, 56 outpatient centers and some 300 Occupational Risk Centers.

Teknon Medical Centre

Teknon Medical Centre is one of the leading hospitals in the Spanish private healthcare sector, thanks to the high quality of its medical staff and care services in a setting that combines individual attention with the full support of the latest health technology. All of which has earned it the prestigious accreditation from the US Joint Commission International as well as the accreditation of inpatient acute care centers of the Generalitat of Catalonia (based on the excellence model of the efqm european foundation for quality management), which makes it one of the few hospitals in Spain to have earned both distinctions. More than 400 top ranked specialists practice on our Campus, all with international training in their respective fields and the ability to attend patients in various languages. A total of more than 2,000 professionals are devoted to the medical care, comfort and personalised service to the patients that choose us.

Les Hôpitaux Universitaires de Genève HUG (groupe)

Les Hôpitaux Universitaires de Genève HUG (Gruppe) (THE LEADING SWISS UNIVERSITY HOSPITAL GROUP) was created in 1995, and is part of a tradition of excellence in medicine and science dating back hundreds of years. The group brings together 10 Geneva public hospitals and 40 outpatient units throughout the canton of Geneva, and together they form the leading Swiss University Hospital. HUG has the only high-security diagnostic laboratory (level 4) in Switzerland. HUG’s geographical location predisposes us to openness and contributes to Geneva's international outlook. Our hospital group works closely with the World Health Organization (WHO), and awarded HUG with referral center status in six areas.

Johner Institut

The Johner Institute assists manufacturers in the worldwide approval of medical devices and in the development and certification of QM systems in accordance with ISO 13485. The Johner Institute compiles and provides technical documentation in accordance with IEC 62304, ISO 14971 and IEC 62366-1 as well as the FDA requirements Topics seminars and e-learning. In his IT Security and Usability Labs in Germany and Washington D.C. It tests the safety and serviceability of medical devices. The extra-occupational Master program "IT in Health Care" promotes the career of specialists and executives.